Eliquis Market: Role in Stroke Prevention and Atrial Fibrillation Treatment

Comments · 8 Views

The Eliquis is related to an oral anticoagulant that helps prevent and treat clots in the bloodstream. Eliquis is mainly used to reduce the risk of stroke in patients diagnosed with atrial fibrillation (AF) and can also be used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE

Eliquis Market Overview:

Jadhavar Business Intelligence is a Business Consultancy Firm that has published a detailed analysis of the “Eliquis Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive landscape. The analysis in the report provides an in-depth aspect at the current status of the Eliquis Market.

Request a Free Sample Copy or View Report Summary:https://www.jadhavarbusinessintelligence.com/request-sample-report/eliquis-market/1073 

Eliquis Market Scope and Methodology:

The Eliquis Market requires a mix of both qualitative and quantitative research methods. Eliquis Market information is gathered through different research methods including expert advice, primary and secondary research, both qualitative and quantitative. Primary research gathers important data from interviews, surveys, questionnaires, and input from industry experts, customers and other sources either in person or over the phone.

The report provides in-depth analysis on different strategies used by leading companies, such as partnerships, mergers, acquisitions, and collaborations. The report conducted a SWOT analysis to evaluate the company's market position through identifying its strengths, weaknesses, opportunities, and threats. Analytical techniques, such as examining investment returns, conducting a feasibility study, and using Porter's five forces analysis, were employed to assess the Eliquis Market. The bottom-up approach was used to determine the global and regional Eliquis Market sizes.

Eliquis Market Regional Insights:

The Eliquis Market report is segmented into various key countries. Countries such as North America (United States, Canada, Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN countries, other APAC countries), South America (Brazil), and the Middle East and Africa.

Request a Free Sample Copy or View Report Summary:https://www.jadhavarbusinessintelligence.com/request-sample-report/eliquis-market/1073 

Eliquis Market Segmentation:

By Indication
Based on Indication, the Eliquis Market is divided into segments including Atrial Fibrillation (AF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Post-Operative Venous Thromboembolism (VTE) Prophylaxis, and Others. The Atrial Fibrillation (AF) segment has taken the lead in the Eliquis Market, capturing 41% of the overall market share in 2024. This leadership is attributed to the rising global incidence of AF, with over 5 million new cases diagnosed annually. For stroke prevention in patients with AF, healthcare providers frequently choose Eliquis due to its reduced bleeding risk in comparison to older treatment options. Furthermore, clinical data and guidelines support its increased use in this particular segment.

By Distribution Channel

According to the Distribution Channel, the Eliquis market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. For example, in 2024, the hospital pharmacy segment led the Eliquis Market, accounting for 46% of the overall market share. Hospitals continue to be the primary starting point for initiating anticoagulation therapies, especially for patients newly diagnosed with DVT and PE. The necessity for close patient monitoring, the involvement of major hospital systems in bulk purchasing, and the preference of physicians for medications to be supplied through hospital pharmacies to ensure adherence and proper dosing during the initial stages of therapy all contributed to the prominence of this channel.

Eliquis Market Key Players:

F. Hoffmann-La Roche Ltd.

Mylan NV

Teva Pharmaceutical Industries Ltd.

Sanofi

Pfizer Inc.

GSK plc

Novartis AG

AstraZeneca

Johnson & Johnson Private Limited

Bristol-Myers Squibb Company

Bayer AG

Sanofi S.A.

Boehringer Ingelheim GmbH

AstraZeneca PLC

Roche Holding AG

Get to Know More About This Market Study:https://www.jadhavarbusinessintelligence.com/market-research-report/eliquis-market/1073 

Key questions answered in the Eliquis Market are:

What is Eliquis Market?

What is the growth rate of the Eliquis Market?

Which are the factors expected to drive the Eliquis Market growth?

What are the upcoming opportunities and trends for the Eliquis Market?

Who are the leading companies and what are their portfolios in Eliquis Market?

What are the recent industry trends that can be implemented to generate additional revenue streams for the Eliquis Market?

Who are the key players in the Eliquis Market?

What are the different segments of the Eliquis Market?

Which is the fastest growing region in the Eliquis Market?

What growth strategies are the players considering to increase their presence in Eliquis Market?

What is the CAGR at which the Eliquis Market will grow during the forecast period?

What segments are covered in the Eliquis Market?

Latest cutting-edge research from Jadhavar Business Intelligence is now trending:

Functional Safety Market https://www.jadhavarbusinessintelligence.com/market-research-report/functional-safety-market/1066                  

First Aid Kit Packaging Market https://www.jadhavarbusinessintelligence.com/market-research-report/first-aid-kit-packaging-market/1067 

Key Offerings:

Past Market Size and Competitive Landscape

Past Pricing and price curve by region

Market Size, Share, Size & Forecast by different segment

Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region

Market Segmentation – A detailed analysis by segment with their sub-segments and Region

Competitive Landscape – Profiles of selected key players by region from a strategic perspective

Competitive landscape – Market Leaders, Market Followers, Regional player

Competitive benchmarking of key players by region

PESTLE Analysis

PORTER’s analysis

Value chain and supply chain analysis

Legal Aspects of Business by Region

Lucrative business opportunities with SWOT analysis

Recommendations

About Jadhavar Business Intelligence:

At Jadhavar Business Intelligence Pvt. Ltd., we believe growth is a collaborative journey. As a leading business consulting and market research company, empowering businesses with data-driven insights, strategic advisory, and investment facilitation. Founded in Pune and rooted in the 30-year legacy of the Jadhavar Group (established in 1995), we empower SMEs, MNCs, startups, NGOs, and educational institutions with data-driven strategies, mentorship, and investment networks to unlock their full potential.

Contact Jadhavar Business Intelligence Pvt. Ltd.:

Address: Office No. 1 & 2, Omkar Building,

Jadhav Nagar Lane No. 1, Vadgaon bk,

Pune - 411041

E-Mail: sales@jadhavarbusinessintelligence.com

Phone: +91 96048 41583

Comments